HIF1A and breast cancer: Consequently, the persistent hypoxic microenvironment and HIF-1α stabilization significantly contribute to the aggressive nature and therapeutic resistance of TNBC, underscoring the need for targeted strategies to mitigate hypoxia-driven pathways in this challenging breast cancer subtype.